» Articles » PMID: 27284403

Role and Molecular Mechanism of Heterogeneous Nuclear Ribonucleoprotein K in Tumor Development and Progression

Overview
Journal Biomed Rep
Specialty Biochemistry
Date 2016 Jun 11
PMID 27284403
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a member of the hnRNP family, which exists in the nucleus and the cytoplasm simultaneously. It is a multifunctional protein that can participate in a variety of regulatory progressions of gene expression and signal transduction, such as chromatin remodeling, transcription, RNA alternative splicing and translation. hnRNP K not only directly binds to the kinases, but also recruits the associated factors regarding transcription, splicing and translation to control gene expression, and therefore, it serves as a docking platform for integrating transduction pathways to nucleic acid-directed processes. Numerous studies also show that abnormal expression of hnRNP K is closely associated with the tumor formation. This protein is overexpressed in numerous types of cancer and its aberrant cytoplasmic localization is also associated with a worse prognosis for patients. These results consistently indicate that hnRNP K has a key role in cancer progression. To understand the hnRNP K pathophysiological process in tumor disease, the previous research results regarding the association between hnRNP K and tumors were reviewed.

Citing Articles

Heterogeneous Ribonucleoprotein K Is a Host Regulatory Factor of Chikungunya Virus Replication in Astrocytes.

Pieterse L, McDonald M, Abraham R, Griffin D Viruses. 2025; 16(12.

PMID: 39772225 PMC: 11680317. DOI: 10.3390/v16121918.


Nucleic acid-binding KH domain proteins influence a spectrum of biological pathways including as part of membrane-localized complexes.

Hasan M, Jeannine Brady L J Struct Biol X. 2024; 10:100106.

PMID: 39040530 PMC: 11261784. DOI: 10.1016/j.yjsbx.2024.100106.


CD271 mRNA/hnRNPA2B1 complex promotes proliferation and stemness in oral and head and neck squamous cell carcinoma.

Mochizuki M, Shibuya-Takahashi R, Kanno S, Adachi S, Fujimori H, Nakazato A Cancer Sci. 2024; 115(7):2346-2359.

PMID: 38710200 PMC: 11247604. DOI: 10.1111/cas.16187.


Role of Heterogeneous Nuclear Ribonucleoproteins in the Cancer-Immune Landscape.

Sudhakaran M, Doseff A Int J Mol Sci. 2023; 24(6).

PMID: 36982162 PMC: 10049280. DOI: 10.3390/ijms24065086.


Overexpression of splicing factor poly(rC)-binding protein 1 elicits cycle arrest, apoptosis induction, and p73 splicing in human cervical carcinoma cells.

Chen Y, Dou Z, Chen X, Zhao D, Che T, Su W J Cancer Res Clin Oncol. 2022; 148(12):3475-3484.

PMID: 35896897 DOI: 10.1007/s00432-022-04170-3.


References
1.
Swanson M, Dreyfuss G . Classification and purification of proteins of heterogeneous nuclear ribonucleoprotein particles by RNA-binding specificities. Mol Cell Biol. 1988; 8(5):2237-41. PMC: 363409. DOI: 10.1128/mcb.8.5.2237-2241.1988. View

2.
Saitoh N, Spahr C, Patterson S, Bubulya P, Neuwald A, Spector D . Proteomic analysis of interchromatin granule clusters. Mol Biol Cell. 2004; 15(8):3876-90. PMC: 491843. DOI: 10.1091/mbc.e04-03-0253. View

3.
Shnyreva M, Schullery D, Suzuki H, Higaki Y, Bomsztyk K . Interaction of two multifunctional proteins. Heterogeneous nuclear ribonucleoprotein K and Y-box-binding protein. J Biol Chem. 2000; 275(20):15498-503. DOI: 10.1074/jbc.275.20.15498. View

4.
Mattick J . The genetic signatures of noncoding RNAs. PLoS Genet. 2009; 5(4):e1000459. PMC: 2667263. DOI: 10.1371/journal.pgen.1000459. View

5.
Barboro P, DArrigo C, Diaspro A, Mormino M, Alberti I, Parodi S . Unraveling the organization of the internal nuclear matrix: RNA-dependent anchoring of NuMA to a lamin scaffold. Exp Cell Res. 2002; 279(2):202-18. DOI: 10.1006/excr.2002.5605. View